Eurand to Present at Cowen Health Care Conference
February 24 2010 - 8:45AM
Marketwired
Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical
company, announced today that it is scheduled to present at the
upcoming Cowen Health Care Conference. John Fraher, Eurand's Chief
Commercial Officer, will be presenting.
Event: Cowen Health Care Conference
Date: Wednesday, March 10, 2010
Time: 11:00 a.m. ET
Location: Boston Marriott Copley Place Hotel, Boston, Mass.
An audio webcast of the presentation will be available by
accessing the investor relations section of Eurand's web site at
www.eurand.com. A replay of the presentation will be available for
30 days.
About Eurand
Eurand is a specialty pharmaceutical company that develops,
manufactures and commercializes enhanced pharmaceutical and
biopharmaceutical products based on its proprietary pharmaceutical
technologies. Eurand has had six products approved by the FDA since
2001 and has a pipeline of product candidates in development for
itself and its collaboration partners. Its technology platforms
include bioavailability enhancement of poorly soluble drugs, custom
release profiles and taste-masking/ orally disintegrating tablet
(ODT) formulations.
Eurand is a global company with facilities in the U.S. and
Europe. For more information, visit Eurand's website at
www.eurand.com.
Contacts: Bill Newbould Vice President, Investor Relations
Eurand N.V. +1 267-759-9335 Email Contact Nick Laudico/Sara
Pellegrino The Ruth Group +1 646-536-7030/7002 Email Contact Email
Contact
Eurand N.V. (MM) (NASDAQ:EURX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Eurand N.V. (MM) (NASDAQ:EURX)
Historical Stock Chart
From Aug 2023 to Aug 2024